Aditya Birla SL Pharma & Healthcare Fund(D)-Direct Plan

16.16 0.39 (2.47%) NAV as on 09-Apr-21
52-Week High ( ) 16.16 (09-Apr-21)
52-Week Low ( ) 12.09 (15-Apr-20)
Type Open ended scheme
Launch Date 10-Jul-19
Net Assets ( Cr ) 454.91
Max Entry Load (%) 0.00
Max Exit Load (%) 0.00
Minimum Investment ( ) 1000

PERFORMANCE

Returns 6M (%) 1Y (%) 3Y (%) Since INC.
Scheme Return11.2246.85NA38.28
Category Avg11.6652.8021.7123.69
Category Best-0.765.063.2019.46
Category Worst-6.89-3.39-6.39-4.00
SENSEX22.4259.1513.64-
NIFTY24.5162.8112.64-

Performance GRAPH

More from Perfomance »

Portfolio Summary

Name of Holding Instrument Hold (%)
Sun Pharmaceutical Industries Ltd.Domestic Equities11.12
Dr. Reddys Laboratories Ltd.Domestic Equities9.77
Cipla Ltd.Domestic Equities9.22
Divis Laboratories Ltd.Domestic Equities8.63
Lupin Ltd.Domestic Equities7.98
More from Portfolio Summary »

INvestment Pattern Details

Type Minimum Maximum
Equities & Equity Linked instruments of comp in the Pharma & Healthcare sec80100
Other Equities & Equity Linked instruments020
Debt and Money Market Instruments020
Units issued by REITs & InvITs010
More from Investment Pattern Details »

Return Calculator

MARKET STATS As on 09/04/2021 As on 09/04/2021

14834.85 (-0.26) 49591.32 (-0.31)

TOP GAINERS

Company Price Change Gain (%)
Blue Chip India0.200.0533.33
Aurionpro Solutions165.6027.6020.00

TOP LOSERS

Company Price Change Loss (%)
Castex Technologies0.35-0.05-12.50
Century Extrusions4.85-0.45-8.49

Portfolio Comparison

MUTUAL FUND ACTIVITY